COSCIENS Biopharma Inc. (CSCI)
NASDAQ: CSCI · Real-Time Price · USD
2.720
-0.040 (-1.45%)
Feb 21, 2025, 4:00 PM EST - Market closed
COSCIENS Biopharma Market Cap
COSCIENS Biopharma has a market cap or net worth of $10.55 million as of February 21, 2025. Its market cap has increased by 21.30% in one year.
Market Cap
10.55M
Enterprise Value
-6.93M
1-Year Change
21.30%
Ranking
Category
Stock Price
2.72
Market Cap Chart
Since December 31, 2001, COSCIENS Biopharma's market cap has decreased from $167.20M to $10.55M, a decrease of -93.69%. That is a compound annual growth rate of -11.25%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Feb 21, 2025 | 8.50M | -1.16% |
Dec 31, 2024 | 8.60M | -4.44% |
Dec 29, 2023 | 9.00M | -41.56% |
Dec 30, 2022 | 15.40M | -64.27% |
Dec 31, 2021 | 43.10M | 61.42% |
Dec 31, 2020 | 26.70M | 78.00% |
Dec 31, 2019 | 15.00M | -68.94% |
Dec 31, 2018 | 48.30M | 58.36% |
Dec 29, 2017 | 30.50M | -14.57% |
Dec 30, 2016 | 35.70M | 1,131.03% |
Dec 31, 2015 | 2.90M | -89.34% |
Dec 31, 2014 | 27.20M | -22.29% |
Dec 31, 2013 | 35.00M | -15.87% |
Dec 31, 2012 | 41.60M | -67.60% |
Dec 30, 2011 | 128.40M | 18.34% |
Dec 31, 2010 | 108.50M | 152.91% |
Dec 31, 2009 | 42.90M | 65.00% |
Dec 31, 2008 | 26.00M | -68.25% |
Dec 31, 2007 | 81.90M | -61.96% |
Dec 29, 2006 | 215.30M | -7.56% |
Dec 30, 2005 | 232.90M | -17.99% |
Dec 31, 2004 | 284.00M | 133.74% |
Dec 31, 2003 | 121.50M | 16.49% |
Dec 31, 2002 | 104.30M | -37.62% |
Dec 31, 2001 | 167.20M | - |
View and export this data all the way back to 2001.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 784.71B |
UnitedHealth Group | 429.24B |
Novo Nordisk | 391.83B |
Johnson & Johnson | 390.76B |
AbbVie | 356.74B |
Abbott Laboratories | 234.01B |
AstraZeneca | 229.50B |
Merck & Co. | 226.40B |